Actual Medicinal Product (AMP) Vildagliptin 50mg / Metformin 1g tablets (Krka UK Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Moisture sensitive medicine. Store in airtight (sealed) MCA. Manufacturer recommends storing in original container. No stability data in MCAs available.
- Provenance
-
This recommendation is based on the products Eucreas 50mg/1,000mg tablets(Novartis Pharmaceuticals UK Ltd) and vildagliptin/metformin 50mg/1,000mg tablets (Krka UK Ltd).
- Generic
- Vildagliptin + Metformin
- Formulation
- Vildagliptin 50mg / Metformin 1g tablets
-
Vildagliptin + Metformin
-
Vildagliptin 50mg / Metformin 1g tablets
-
Vildagliptin 50mg / Metformin 1g tablets (Krka UK Ltd)
-
-